Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
116
Views
25
CrossRef citations to date
0
Altmetric
Review

Clinical targeting recombinant immunotoxins for cancer therapy

Meng Li1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Zeng-Shan Liu1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Xi-Lin Liu1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Qi Hui2 School of Pharmacy, Wenzhou Medical University, Wenzhou, People’s Republic of China
,
Shi-Ying Lu1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Lin-Lin Qu1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Yan-Song Li1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Yu Zhou1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, Changchun
,
Hong-Lin Ren1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, ChangchunCorrespondence[email protected] [email protected]
&
Pan Hu1 Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, China-Japan Union Hospital, The First Hospital, Jilin University, ChangchunCorrespondence[email protected] [email protected]
 show all
Pages 3645-3665 | Published online: 20 Jul 2017

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mohammad Reza Khirehgesh, Jafar Sharifi, Fatemeh Safari & Bahman Akbari. (2021) Immunotoxins and nanobody-based immunotoxins: review and update. Journal of Drug Targeting 29:8, pages 848-862.
Read now

Articles from other publishers (24)

Jaepyeong Jang, Minh Quan Nguyen, Sangsu Park, Dayoung Ryu, Hyeseon Park, Gunsup Lee, Chong Jai Kim, Yeon Jin Jang & Han Choe. (2023) Crotamine-based recombinant immunotoxin targeting HER2 for enhanced cancer cell specificity and cytotoxicity. Toxicon 230, pages 107157.
Crossref
Derya Demir, Mine Hekimgil, Emin Karaca, Yusuf Ulusoy, Hamiyet Hekimci Özdemir, Güray Saydam, Burak Durmaz, Haluk Akın, Nazan Çetingül, Murat Tombuloğlu & Nazan Özsan. (2023) Clinicopathological characteristics, genetics and prognosis of patients with myeloid sarcoma: a single-center study. Journal of Clinical Pathology 76:4, pages 244-251.
Crossref
Javier Narbona, Rubén G. Gordo, Jaime Tomé-Amat & Javier Lacadena. (2023) A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin. Cancers 15:4, pages 1114.
Crossref
Brad Bolon, Francisco A. Uzal & Melissa Schutten. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 3. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 3 629 678 .
Simon K. Krebs, Marlitt Stech, Felix Jorde, Nathanaël Rakotoarinoro, Franziska Ramm, Sophie Marinoff, Sven Bahrke, Antje Danielczyk, Doreen A. Wüstenhagen & Stefan Kubick. (2022) Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems. International Journal of Molecular Sciences 23:22, pages 13697.
Crossref
Lucia Salvioni, Filippo Testa, Linda Barbieri, Marco Giustra, Jessica Armida Bertolini, Giulia Tomaino, Paolo Tortora, Davide Prosperi & Miriam Colombo. (2022) Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells. Pharmaceutics 14:7, pages 1517.
Crossref
Hossein Panjideh, Nicole Niesler, Alexander Weng & Hendrik Fuchs. (2022) Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 14:7, pages 478.
Crossref
Yue Du & Jian Xu. (2021) Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges. Advanced Materials 33:48.
Crossref
Virginia Metrangolo, Michael Ploug & Lars H. Engelholm. (2021) The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities. Cancers 13:21, pages 5376.
Crossref
Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian & Ehsan Rezaie. (2021) Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect. Toxins 13:10, pages 719.
Crossref
Victor Pallarès, Yáiza Núñez, Laura Sánchez-García, Aïda Falgàs, Naroa Serna, Ugutz Unzueta, Alberto Gallardo, Lorena Alba-Castellón, Patricia Álamo, Jorge Sierra, Antonio Villaverde, Esther Vázquez, Isolda Casanova & Ramon Mangues. (2021) Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4. Journal of Controlled Release 335, pages 117-129.
Crossref
Michelle Yee Mun Teo, Jeremy Jeack Ceen Ng, Jung Yin Fong, Jung Shan Hwang, Adelene Ai-Lian Song, Renee Lay Hong Lim & Lionel Lian Aun In. (2021) Development of a single-chain fragment variable fused-mutant HALT-1 recombinant immunotoxin against G12V mutated KRAS c olorectal cancer cells . PeerJ 9, pages e11063.
Crossref
Camilo Torres, Simon Dumas, Valentina Palacio-Castañeda, Stéphanie Descroix, Roland Brock & Wouter P. R. Verdurmen. (2021) A Computational Investigation of In Vivo Cytosolic Protein Delivery for Cancer Therapy. Pharmaceutics 13:4, pages 562.
Crossref
Amirhossein Kazemian & Pardis Nematollahi. (2021) Evaluation of CD30 expression in B ALL and its correlation with MRD(Minimum Residual Disease). Journal of Research in Medical Sciences 26:1, pages 90.
Crossref
Bilge Özerman Edis, Muhammet Bektaş & Rüstem Nurten. (2020) Myofibrillar degeneration with diphtheria toxin. Turkish Journal of Biochemistry 45:4, pages 351-357.
Crossref
Antonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, Rong Qiu, Robert Sarnvosky & David J. FitzGerald. (2020) Targeting Receptors on Cancer Cells with Protein Toxins. Biomolecules 10:9, pages 1331.
Crossref
Santos Ramírez-Carreto, Beatriz Miranda-Zaragoza & Claudia Rodríguez-Almazán. (2020) Actinoporins: From the Structure and Function to the Generation of Biotechnological and Therapeutic Tools. Biomolecules 10:4, pages 539.
Crossref
Lara Šošić, Pål Kristian Selbo, Zuzanna K. Kotkowska, Thomas M. Kündig, Anders Høgset & Pål Johansen. (2020) Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines. Cancers 12:1, pages 165.
Crossref
Ji-Sun Kim, Sei-Yong Jun & Yong-Sung Kim. (2020) Critical Issues in the Development of Immunotoxins for Anticancer Therapy. Journal of Pharmaceutical Sciences 109:1, pages 104-115.
Crossref
Ana Santos Cravo & Randall Mrsny. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 1 22 .
Mahesh Agarwal, Tanmay Mondal & Biplab Bose. (2019) Peptides derived from a short stretch of diphtheria toxin bind to heparin-binding epidermal growth factor-like growth factor. Toxicon 169, pages 109-116.
Crossref
Hyun-Jong Ahn, Cheung-Seog Park & Jeong Je Cho. (2019) Application of therapeutic protein-based fusion toxins. Molecular & Cellular Toxicology 15:4, pages 369-381.
Crossref
Lucía Martínez-Jothar, Nataliia Beztsinna, Cornelus F. van Nostrum, Wim E. Hennink & Sabrina Oliveira. (2019) Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization. Molecular Pharmaceutics 16:4, pages 1633-1647.
Crossref
Aleksander Rust, Lynda Partridge, Bazbek Davletov & Guillaume Hautbergue. (2017) The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations. Toxins 9:11, pages 344.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.